Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

20 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Amide conjugates of the jasmonate precursor cis-(+)-12-oxo-phytodienoic acid regulate its homeostasis during plant stress responses.
Široká J, Ament A, Mik V, Pospíšil T, Kralová M, Zhang C, Pernisová M, Karady M, Nožková V, Nishizato Y, Kaji T, Saito R, Htitich M, Floková K, Wasternack C, Strnad M, Ueda M, Novák O, Brunoni F. Široká J, et al. Among authors: nishizato y. Plant Physiol. 2024 Dec 23;197(1):kiae636. doi: 10.1093/plphys/kiae636. Plant Physiol. 2024. PMID: 39607728 Free PMC article.
Δ4-dn-iso-OPDA, a bioactive plant hormone of Marchantia polymorpha.
Kaji T, Nishizato Y, Yoshimatsu H, Yoda A, Liang W, Chini A, Fernández-Barbero G, Nozawa K, Kyozuka J, Solano R, Ueda M. Kaji T, et al. Among authors: nishizato y. iScience. 2024 Jun 6;27(7):110191. doi: 10.1016/j.isci.2024.110191. eCollection 2024 Jul 19. iScience. 2024. PMID: 38974968 Free PMC article.
Valuable interaction with cognitive remediation and optimal antipsychotics for recovery in schizophrenia (VICTORY-S): study protocol for an interventional, open-label, randomized comparison of combined treatment with cognitive remediation and lurasidone or paliperidone.
Kubota R, Ikezawa S, Oi H, Oba MS, Izumi S, Tsuno R, Adachi L, Miwa M, Toya S, Nishizato Y, Haga D, Iwane T, Nakagome K. Kubota R, et al. Among authors: nishizato y. Front Psychiatry. 2024 Feb 6;14:1331356. doi: 10.3389/fpsyt.2023.1331356. eCollection 2023. Front Psychiatry. 2024. PMID: 38380376 Free PMC article.
A Novel Phosphodiesterase 1 Inhibitor DSR-141562 Exhibits Efficacies in Animal Models for Positive, Negative, and Cognitive Symptoms Associated with Schizophrenia.
Enomoto T, Tatara A, Goda M, Nishizato Y, Nishigori K, Kitamura A, Kamada M, Taga S, Hashimoto T, Ikeda K, Fujii Y. Enomoto T, et al. Among authors: nishizato y. J Pharmacol Exp Ther. 2019 Dec;371(3):692-702. doi: 10.1124/jpet.119.260869. Epub 2019 Oct 2. J Pharmacol Exp Ther. 2019. PMID: 31578257
Effects of calcium channel blocker benidipine-based combination therapy on target blood pressure control and cardiovascular outcome: a sub-analysis of the COPE trial.
Umemoto S, Ogihara T, Matsuzaki M, Rakugi H, Ohashi Y, Saruta T; Combination Therapy of Hypertension to Prevent Cardiovascular Events (COPE) Trial Group. Umemoto S, et al. Hypertens Res. 2017 Apr;40(4):376-384. doi: 10.1038/hr.2016.158. Epub 2016 Dec 1. Hypertens Res. 2017. PMID: 27904156 Free PMC article. Clinical Trial.
Effects of calcium channel blocker-based combinations on intra-individual blood pressure variability: post hoc analysis of the COPE trial.
Umemoto S, Ogihara T, Matsuzaki M, Rakugi H, Ohashi Y, Saruta T; Combination Therapy of Hypertension to Prevent Cardiovascular Events COPE Trial Group. Umemoto S, et al. Hypertens Res. 2016 Jan;39(1):46-53. doi: 10.1038/hr.2015.104. Epub 2015 Oct 22. Hypertens Res. 2016. PMID: 26490089 Free PMC article. Clinical Trial.
Combination therapy for hypertension in patients with CKD: a subanalysis of the Combination Therapy of Hypertension to Prevent Cardiovascular Events trial.
Rakugi H, Ogihara T, Umemoto S, Matsuzaki M, Matsuoka H, Shimada K, Higaki J, Ito S, Kamiya A, Suzuki H, Ohashi Y, Shimamoto K, Saruta T; Combination Therapy of Hypertension to Prevent Cardiovascular Events Trial Group. Rakugi H, et al. Hypertens Res. 2013 Nov;36(11):947-58. doi: 10.1038/hr.2013.63. Epub 2013 Jul 18. Hypertens Res. 2013. PMID: 23864054 Clinical Trial.
20 results